Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study

Although messenger RNA (mRNA) vaccines have established efficacy for prevention of severe SARS-CoV2 infection in the general population, their effectiveness in patients with malignancy, especially those on anti-neoplastic therapies, remains an area of open research. In order to better understand the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rooney, Anthony, Bivona, Cory, Liu, Ben, Streeter, David, Gong, Han, Khan, Qamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123710/
https://www.ncbi.nlm.nih.gov/pubmed/35597960
http://dx.doi.org/10.1186/s13045-022-01290-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123710/
https://www.ncbi.nlm.nih.gov/pubmed/35597960
http://dx.doi.org/10.1186/s13045-022-01290-8

Ejemplares similares